Literature DB >> 15601861

WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice.

Wendy E Kutz1, Yaoqin Gong, Matthew L Warman.   

Abstract

In humans, loss-of-function mutations in WISP3 cause the autosomal recessive skeletal disease progressive pseudorheumatoid dysplasia (PPD) (Online Mendelian Inheritance in Man database number 208230). WISP3 encodes Wnt1-inducible signaling protein 3, a cysteine-rich, multidomain, secreted protein, whose paralogous CCN (connective tissue growth factor/cysteine-rich protein 61/nephroblastoma overexpressed) family members have been implicated in diverse biologic processes including skeletal, vascular, and neural development. To understand the role of WISP3 in the skeleton, we targeted the Wisp3 gene in mice by creating a mutant allele comparable to that which causes human disease. We also created transgenic mice that overexpress human WISP3 in cartilage. Surprisingly, homozygous Wisp3 mutant mice appear normal and do not recapitulate any of the morphological, radiographic, or histological abnormalities seen in patients with PPD. Mice that overexpress WISP3 are also normal. We conclude, that in contrast to humans, Wisp3 is not an essential participant during skeletal growth or homeostasis in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15601861      PMCID: PMC538768          DOI: 10.1128/MCB.25.1.414-421.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  26 in total

1.  The CCN family of genes: a brief history.

Authors:  B Perbal
Journal:  Mol Pathol       Date:  2001-04

Review 2.  NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.

Authors:  B Perbal
Journal:  Mol Pathol       Date:  2001-04

3.  Mega os trigonum in progressive pseudorheumatoid dysplasia.

Authors:  Alan E Oestreich
Journal:  Pediatr Radiol       Date:  2001-11-08

4.  Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism.

Authors:  T Nakanishi; T Yamaai; M Asano; K Nawachi; M Suzuki; T Sugimoto; M Takigawa
Journal:  Biochem Biophys Res Commun       Date:  2001-03-02       Impact factor: 3.575

Review 5.  In vivo morphometry and functional analysis of human articular cartilage with quantitative magnetic resonance imaging--from image to data, from data to theory.

Authors:  F Eckstein; M Reiser; K H Englmeier; R Putz
Journal:  Anat Embryol (Berl)       Date:  2001-03

6.  Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies.

Authors:  S Ogueta; I Olazabal; I Santos; E Delgado-Baeza; J P García-Ruiz
Journal:  J Endocrinol       Date:  2000-05       Impact factor: 4.286

7.  Cartilage oligomeric matrix protein-deficient mice have normal skeletal development.

Authors:  Liz Svensson; Attila Aszódi; Dick Heinegård; Ernst B Hunziker; Finn P Reinholt; Reinhard Fässler; Ake Oldberg
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

8.  Lifelong voluntary joint loading increases osteoarthritis in mice housing a deletion mutation in type II procollagen gene, and slightly also in non-transgenic mice.

Authors:  T Lapveteläinen; M M Hyttinen; A-M Säämänen; T Långsjö; J Sahlman; S Felszeghy; E Vuorio; H J Helminen
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

9.  CYR61 (CCN1) is essential for placental development and vascular integrity.

Authors:  Fan-E Mo; Andrew G Muntean; Chih-Chiun Chen; Donna B Stolz; Simon C Watkins; Lester F Lau
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

10.  WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.

Authors:  Celina G Kleer; Yanhong Zhang; Quintin Pan; Kenneth L van Golen; Zhi-Fen Wu; D Livant; Sofia D Merajver
Journal:  Oncogene       Date:  2002-05-09       Impact factor: 9.867

View more
  33 in total

1.  Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice.

Authors:  Ernesto Canalis; Stefano Zanotti; Wesley G Beamer; Aris N Economides; Anna Smerdel-Ramoya
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 2.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

3.  Dual regulation of metalloproteinase expression in chondrocytes by Wnt-1-inducible signaling pathway protein 3/CCN6.

Authors:  Natasha Baker; Paul Sharpe; Kirsty Culley; Miguel Otero; Damon Bevan; Peter Newham; Wendy Barker; Kristen M Clements; Caroline J Langham; Mary B Goldring; Jelena Gavrilović
Journal:  Arthritis Rheum       Date:  2012-07

Review 4.  The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.

Authors:  Guo-Wei Zuo; Christopher D Kohls; Bai-Cheng He; Liang Chen; Wenli Zhang; Qiong Shi; Bing-Qiang Zhang; Quan Kang; Jinyong Luo; Xiaoji Luo; Eric R Wagner; Stephanie H Kim; Farbod Restegar; Rex C Haydon; Zhong-Liang Deng; Hue H Luu; Tong-Chuan He; Qing Luo
Journal:  Histol Histopathol       Date:  2010-06       Impact factor: 2.303

Review 5.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

6.  Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast.

Authors:  Michael J Hayes; Dafydd Thomas; Agnieszka Emmons; Thomas J Giordano; Celina G Kleer
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

Review 7.  Disorders of the growth plate.

Authors:  Chanika Phornphutkul; Philip A Gruppuso
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-12       Impact factor: 3.243

8.  The CCN family of genes: a perspective on CCN biology and therapeutic potential.

Authors:  Herman Yeger; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2008-06-21       Impact factor: 5.782

9.  The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling.

Authors:  Yukio Nakamura; Gilbert Weidinger; Jennifer O Liang; Allisan Aquilina-Beck; Keiko Tamai; Randall T Moon; Matthew L Warman
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

10.  Domain-and species-specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5.

Authors:  Lan Wei; Frank McKeon; Joshua W Russo; Joan Lemire; John Castellot
Journal:  J Cell Commun Signal       Date:  2009-04-29       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.